Affiliations 

  • 1 Clinical Research Centre Sarawak General Hospital, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Kuching, Malaysia. kingtl@crc.moh.gov.my
  • 2 Clinical Research Centre Sarawak General Hospital, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Kuching, Malaysia
  • 3 Department of Radiotherapy, Oncology, and Palliative Care, Sarawak General Hospital, Ministry of Health, Kuching, Malaysia
Sci Rep, 2025 Jan 10;15(1):1626.
PMID: 39794348 DOI: 10.1038/s41598-024-83626-7

Abstract

Despite the expanding landscape of clinical trials, there is a lack of study concerning Malaysian patients' participation and perspectives. This study addresses these gaps by assessing patients' willingness, knowledge, perceptions, confidence, and religious barriers related to clinical trial participations at Sarawak General Hospital. We conducted a cross-sectional survey from March to September 2022 on 763 cancer and non-cancer patients. We collected patients' responses and calculated scores for willingness to participate (40.5/100), knowledge (29.9/100), perceived benefits (66.5/100) and risks (72.4/100) of participations, confidence in clinical trial conducts (66.3/100), and religious barriers (49.8/100). The higher scores indicated greater willingness, better knowledge, stronger perceptions of benefits and risk, increased confidence, and stronger religious barriers. Cancer patient demonstrated significantly greater willingness for trials involving new drugs (31.9/100 vs. 27.4/100, p = 0.021) but slightly higher religious barriers compared to non-cancer cohort (51.4/100 vs. 48.3/100, p = 0.006). Multivariable logistic regression identified female gender, unemployment, poor knowledge, low perceived benefits, high perceived risks, and low confidence as significant factors associated with reduced willingness to participate (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.